Simplifi797 compounding pharmacy
HealthOctober 03, 2019

Webinar: Preparing for USP 797 enforcement: 30 priorities in the next 60 days

Compounding expert, Eric S. Kastango, BS Pharm, MBA, FASHP, discusses the announcement from USP and recommends best practices to move forward.

On Monday, September 23, 2019, United States Pharamacopeia (USP) announced it is postponing enforcement of USP Chapters <795>, <797> and <825> originally scheduled for December 1, 2019 after receiving appeals on certain provisions. Additionally, it announced USP Chapter <800> is not subject to any pending appeals and will become official on December 1, 2019, however is considered informational and not compendially applicable during the postponement and pending resolutions of appeals of <795> and <797>.

Additionally, we discuss areas to prioritize and proactively address for USP 797 compliance.

The following topic areas are explored in addition to others:

  • Assigning Beyond-use Dates
  • The use of Master Formulation and Compounding Records
  • Best practices for Air & Surface Sampling
  • Establishing a Designated Person
  • Review of Engineering Controls
  • Requirements for Personal Hygiene & Garbing

Access the on-demand webinar

Solutions
Simplifi 797®

Take the guesswork out of USP medication compounding compliance with a customizable, mobile, evidence-based solution.

 

Simplifi 797 provides the latest evidence-based guidance and helps navigate the complex USP Chapters 795, 797 and 800 processes to ensure inspection confidence and keep patients and staff safe.